Dr. Jan Stahl resigned May 11, 2006
Also 8-K below shows 29-Jun-2006
Unregistered Sale of Equity Securities, Change in Directors or Principal Officers.
Item 3.02 Unregistered Sales of Equity Securities
On June 26, 2006, the board directors approved the issuance of 1,008,561 Series A Convertible Preferred Shares to the former Chief Executive Officer of the Registrant for the exchange of 10,085,614 common shares of the Registrant. The Series A Convertible Preferred Shares will be issued as restricted securities and are exempt from registration under §5 of the Securities Act of 1933, as the issuances are deemed exempt from registration under §3(a)(9), §4(1) and 4(2) of the Securities Act of 1933.
*******************************************************
PAIVIS, CORP. (formerly APO Health, Inc.)
DATED: MAY 11, 2006
RESIGNATION FROM BOARD OF DIRECTORS AND ELECTION OF
NEW DIRECTORS AND OFFICERS
The undersigned, being a member of the Board of Directors and Officer of Paivis, Corp., formerly APO Health, Inc., hereby resigns from the Board of Directors and as the President effective immediately, and hereby appoints the following officers and directors effective as of the date hereof:
President - Gregory L. Bauer
Treasurer - Gregory L. Bauer
Secretary - Cathy Wilson
Director - Gregory L. Bauer
Director - Guriqbal Randhawa
/s/ Dr. Jan Stahl
Dr. Jan Stahl
The undersigned, being a member of the Board of Directors and Officer of Paivis, Corp., formerly APO Health, Inc., hereby resigns from the Board of Directors and as the President effective immediately, and hereby appoints the following officers and directors effective the date hereof:
President - Gregory L. Bauer
Treasurer - Gregory L. Bauer
Secretary - Cathy Wilson
Director - Gregory L. Bauer
Director - Guriqbal Randhawa
/s/ Kenny Leventhal
Kenny Leventhal
ACCEPTANCE OF APPOINTMENT TO THE BOARD OF DIRECTORS AND OFFICERS
I, the undersigned, do hereby accept the appointment of President, Treasurer and Director , effective immediately.
/s/ Gregory L. Bauer
Gregory L. Bauer
I, the undersigned, do hereby accept the appointment of Secretary .
/s/ Cathy Wilson
Cathy Wilson
I, the undersigned, do hereby accept the appointment of Director , effective immediately.
/s/ Guriqbal Randhawa
Guriqbal Randhawa
**************************************************************
Form 8-K for APO HEALTH INC /NV/
29-Jun-2006
Unregistered Sale of Equity Securities, Change in Directors or Principal Offi
Item 3.02 Unregistered Sales of Equity Securities
On June 26, 2006, the board directors approved the issuance of 1,008,561 Series A Convertible Preferred Shares to the former Chief Executive Officer of the Registrant for the exchange of 10,085,614 common shares of the Registrant. The Series A Convertible Preferred Shares will be issued as restricted securities and are exempt from registration under §5 of the Securities Act of 1933, as the issuances are deemed exempt from registration under §3(a)(9), §4(1) and 4(2) of the Securities Act of 1933.
On June 26, 2006, the board directors approved the issuance of 2,500,750 Series B Convertible Preferred Shares to a corporation controlled by a director of the Registrant for the exchange of 200,060,000 Series B Convertible Shares of Jupiter Global Holdings Corp. (a subsidiary of the Registrant). The Series B Convertible Preferred Shares will be issued as restricted securities and are exempt from registration under §5 of the Securities Act of 1933, as the issuances are deemed exempt from registration under §3(a)(9), §4(1) and 4(2) of the Securities Act of 1933.
On June 26, 2006, the board directors approved the issuance of 500,000 Series B Convertible Preferred Shares to a corporation controlled by a officer and director of the Registrant for the exchange of 50,000,000 Series C Convertible Shares of Jupiter Global Holdings Corp. (a subsidiary of the Registrant). The Series B Convertible Preferred Shares will be issued as restricted securities and are exempt from registration under §5 of the Securities Act of 1933, as the issuances are deemed exempt from registration under §3(a)(9), §4(1) and 4(2) of the Securities Act of 1933.
